Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Angiogenesis. 2024 Aug;27(3):475-499. doi: 10.1007/s10456-024-09922-y. Epub 2024 May 13.
Aging is a natural process associated with chronic inflammation in the development of vascular dysfunction. We hypothesized that chemokine C-C motif ligands 4 (CCL4) might play a vital role in aging-related vascular dysfunction. Circulating CCL4 was up-regulated in elderly subjects and in aged animals. CCL4 inhibition reduced generation of reactive oxygen species (ROS), attenuated inflammation, and restored cell functions in endothelial progenitor cells from elderly subjects and in aged human aortic endothelial cells. CCL4 promoted cell aging, with impaired cell functioning, by activating ROS production and inflammation. CCL4 knockout mice and therapeutic administration of anti-CCL4 neutralizing antibodies exhibited vascular and dermal anti-aging effects, with improved wound healing, via the down-regulation of inflammatory proteins and the activation of angiogenic proteins. Altogether, our findings suggested that CCL4 may contribute to aging-related vascular dysfunction via activating oxidative stress and endothelial inflammation. CCL4 may be a potential therapeutic target for vascular protections during aging.
衰老是一个与血管功能障碍发展过程中的慢性炎症相关的自然过程。我们假设趋化因子 C-C 基元配体 4 (CCL4) 可能在与年龄相关的血管功能障碍中发挥重要作用。循环 CCL4 在老年受试者和老年动物中上调。CCL4 抑制可减少活性氧 (ROS) 的产生,减轻炎症,并恢复来自老年受试者和老年人类主动脉内皮细胞的内皮祖细胞的细胞功能。CCL4 通过激活 ROS 产生和炎症促进细胞衰老,导致细胞功能障碍。CCL4 敲除小鼠和抗 CCL4 中和抗体的治疗给药表现出血管和皮肤的抗衰老作用,通过下调炎症蛋白和激活血管生成蛋白,改善伤口愈合。总之,我们的研究结果表明,CCL4 可能通过激活氧化应激和内皮炎症导致与年龄相关的血管功能障碍。CCL4 可能是衰老过程中血管保护的潜在治疗靶点。